Effects of lappaconitine hydrobromide on qt interval in patients with paroxysmal atrial fibrillation

M. G. Nazarkina, V. V. Stolyarova, L. M. Mosina, N. M. Selezneva, T. A. Rybakova
2018 Medical Council  
doi:10.21518/2079-701x-2018-5-118-120 fatcat:xsplxbtttvfs7iadznbgjdqsr4